Prelude Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,581
Closed -$4.62M 1461
2023
Q4
$4.62M Buy
+14,581
New +$4.62M 0.31% 53
2023
Q2
Sell
-1,726
Closed -$314K 1339
2023
Q1
$314K Buy
+1,726
New +$314K 0.02% 556
2022
Q4
Sell
-1,514
Closed -$341K 1593
2022
Q3
$341K Buy
+1,514
New +$341K 0.01% 794